Procaps Group SA (PROC)

  • Get an in-depth profile of Procaps Group SA, including a general overview of the company's business and key management, as well as employee data and location and contact information.
2.99 +0.02 (+0.67%)
Real-time Cboe USD Disclaimer

Procaps Group SA Company Profile

Industry
Investment Holding Companies
Sector
Financial
Employees
5500
Equity Type
ORD
Procaps Group S.A. develops, produces, and markets pharmaceutical solutions worldwide. The company formulates, manufactures, and markets branded prescription drugs in various therapeutic areas, including feminine care products, pain relief, skin care, digestive health, growth and development, cardiology, vision care, central nervous system, and respiratory. It also provides drugs for hospital use, such as antibiotic, blood clot, personal protective equipment, immunosuppressant, oncology, and analgesics products. In addition, the company offers over-the-counter (OTC) consumer healthcare products through a portfolio on approximately eight therapeutic areas, including gastrointestinal, skin care, cough and cold, analgesics, urological, vitamins, minerals, and supplements in the categories of antibiotics, anti-infective, anti-parasitic, cardiovascular, feminine care, cutaneous antimycotic, pain killers, gastro intestinal, hormonals, metabolic, endocrine, nervous system, ophthalmic, osteoarticular, respiratory, diet supplements, and vitamins and minerals. Further, it provides blood glucose meters, telemonitoring products, oral anti-diabetics products, cosmeceuticals, insulin delivery systems, and other diabetes solutions; and contract drug development and manufacturing services to third party pharmaceutical companies, specializing in soft gelatin capsule technologies. The company was founded in 1977 and is based in Luxembourg, Luxembourg.
Contact Information
Address
Luxembourg City,1273 Luxembourg
Phone
356 7995 6138
Fax
-
Web
https://www.procapsgroup.com
Top Executives
Name
Age
Since
Title
Ruben Minski 69 1976 Founder, CEO & Chairman
Luis Fernando Castro Vergara 54 0000 Independent Director
Jose Minski 63 0000 Director
David Yanovich Wancier 0 0000 Independent Director
Daniel W. Fink 44 2021 Board Observer
Kyle Philip Bransfield 38 2021 Independent Director
Alberto Eguiguren Correa 58 2023 Independent Director
Sandra Sanchez y Oldenhage 0 2023 Independent Director

Customize

Clear All
0Selected
Please try another search

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.

Related Articles